Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
Addict Biology, 22(5), 1119-1159
The peptide BPC-157 is primarily known for its ability to accelerate tissue repair and recovery, particularly in tendons, ligaments, and muscles
In every case we've tracked, this coincides with either (a) return to baseline-poor sleep habits, (b) increased stress/cortisol load, or (c) dietary regression
Results can often be felt within a few days of the first injection, with optimal benefits over regular treatments
Im particularly grateful to Dr Josh for his clear, candid explanations and honesty throughout, which made the whole experience very reassuring